Search

alt
0500

FiltersClear filters

Status
Sex
Age

Pfizer clinical trials

Search Results

We found 143 clinical trials for: 150 miles

Recruiting
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
  • Recruiting
NCT07282665
Sex: All
Age: 65+
Locations: 158
View study
Recruiting
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
  • Recruiting
NCT06966453
Sex: All
Age: 18+
Locations: 166
View study
Recruiting
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
  • Recruiting
NCT06991257
Sex: All
Age: 18 - 79
Locations: 133
View study
Recruiting
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
  • Recruiting
NCT07144280
Sex: All
Age: 18+
Locations: 305
View study
Recruiting
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
  • Recruiting
NCT07222800
Sex: All
Age: 18+
Locations: 156
View study
Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
  • Recruiting
NCT07222566
Sex: All
Age: 18+
Locations: 229
View study
Recruiting
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
  • Recruiting
NCT06952660
Sex: Female
Age: 18+
Locations: 93
View study
Recruiting
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
  • Recruiting
NCT06758401
Sex: All
Age: 18+
Locations: 329
View study
Recruiting
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
  • Recruiting
NCT07476287
Sex: All
Age: 18+
Locations: 3
View study
Recruiting
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
  • Recruiting
NCT07062965
Sex: All
Age: 18+
Locations: 371
View study
...